Evidence map›Paper›PMID 40329978›Full record

ArticleClinical parkinsonism & related disorders2025

Longitudinal Assessment of Parkinson's Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCAN.

Amir Hossein Najmi, Armin Ariaei, Mahboobeh Khezri, Masoud Noroozi, Melika Arab Bafrani, Avesta Gheysari, Farideh Sabetghadam, Mehdi Ahmadi, Mohammad Sadeghi, Mahsa Mayeli and 1 more

Abstract read
In one paragraph

Article in Clinical parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Early parkinson's disease: levodopa requirements are associated with the striatal DaT-uptake.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Amir Hossein NajmiSchool of Medicine, North Khorasan University of Medical Sciences, North Khorasan, Iran.
Armin AriaeiCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Mahboobeh KhezriSchool of Medicine, Jundishapur University of Medical Sciences, Khuzestan, Iran.
Masoud NorooziDepartment of Biomedical Engineering, Faculty of Engineering, University of Isfahan, Isfahan, Iran.
Melika Arab BafraniSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Avesta GheysariDepartment of Cell and Molecular Biology and Microbiology, Faculty of Biological Sciences and Technology, University of Isfahan, Isfahan, Iran.
Farideh SabetghadamDepartment of Psychology, Faculty of Psychology, Islamic Azad University Najafabad Branch, Isfahan, Iran.
Mehdi AhmadiSchool of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad SadeghiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mahsa MayeliSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Parkinson’s Progression Markers Initiative

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Determining Parkinson's disease (PD) stage and severity are among the factors affecting treatment strategy. Dopamine transporter scan (DaTSCAN) has high efficiency in the diagnosis of PD, while its role in predicting motor function, dyskinesia, and symptoms severity trajectory remains controversial. This study aimed to evaluate the associations between motor symptoms patterns in PD with DaTscan findings. Methods: A total of 196 patients were included and grouped based on tremor score, postural instability and gait difficulty score, and the presentation of dyskinesia. Multivariate and ordinal logistic regression models were used to investigate the association between two-year follow-up of the PD patients' motor symptoms assessment scores and DaTSCAN finding patterns. Results: Patients with dyskinesia exhibited significantly lower DaTSCAN uptake across all measured regions, with the most pronounced reductions observed in the right caudate and left putamen (p < 0.001). Additionally, DaTSCAN values were strongly associated with overall disease severity (p < 0.001). A notable positive correlation was found between DaTSCAN uptake and Schwab and England Activities of Daily Living (ADL) scores, whereas significant negative correlations were observed between DaTSCAN measures (including the caudate, putamen, and anterior putamen) and clinical motor scores, such as MDS-UPDRS III, MDS-UPDRS II, and PIGD. In contrast, DaTSCAN parameters did not significantly predict tremor-dominant (TD) scores. Conclusion: Beyond its diagnostic utility, DaTSCAN provides meaningful insights into disease severity and motor dysfunction in PD, with particular relevance to postural instability and gait disturbance.

Indexed as

DaTSCANDyskinesiaMotor symptomsParkinson’s disease

Identifiers

PMID40329978
PMCPMC12054110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.